Novavax Inc

NVV1

Company Profile

  • Business description

    Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

  • Contact

    700 Quince Orchard Road
    GaithersburgMD20878
    USA

    T: +1 240 268-2000

    E: [email protected]

    https://www.novavax.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,992

Stocks News & Analysis

stocks

Are there signs of an AI bubble in Nvidia’s earnings?

Our view after third-quarter results.
stocks

Picking dividend shares in 2026? Here’s where to look

A new report from Morningstar shows opportunities for income investors.
stocks

Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?

With outstanding long-term estimates, here’s what we think of Nvidia stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,686.308.30-0.10%
CAC 407,989.448.370.10%
DAX 4023,091.87186.98-0.80%
Dow JONES (US)46,245.41493.151.08%
FTSE 1009,531.013.360.04%
HKSE25,220.02615.55-2.38%
NASDAQ22,273.08195.030.88%
Nikkei 22548,625.881,198.06-2.40%
NZX 50 Index13,419.4020.00-0.15%
S&P 5006,602.9964.230.98%
S&P/ASX 2008,416.500.000.00%
SSE Composite Index3,834.8996.16-2.45%

Market Movers